These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32961253)

  • 1. Seroprevalence of SARS-CoV-2 significantly varies with age: Preliminary results from a mass population screening.
    Pagani G; Conti F; Giacomelli A; Bernacchia D; Rondanin R; Prina A; Scolari V; Gandolfi CE; Castaldi S; Marano G; Ottomano C; Boracchi P; Biganzoli E; Galli M
    J Infect; 2020 Dec; 81(6):e10-e12. PubMed ID: 32961253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 seroprevalence in the Vatican City State.
    Ralli M; Arcangeli A; Soave PM; Voglino MC; De-Giorgio F
    Eur J Intern Med; 2021 Apr; 86():98-99. PubMed ID: 33581980
    [No Abstract]   [Full Text] [Related]  

  • 4. The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France.
    Dimeglio C; Loubes JM; Deporte B; Dubois M; Latour J; Mansuy JM; Izopet J
    J Infect; 2020 Aug; 81(2):318-356. PubMed ID: 32360497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High SARS-CoV-2 seroprevalence in HIV patients originating from sub-Saharan Africa in the Ile-de-France area: Seroprevalence of SARS-CoV-2 in HIV patients.
    Abdi B; Ndoadoumgue AL; Djebara S; Zafilaza K; Palich R; Marot S; Schneider L; Wirden M; Seang S; Dudoit Y; Teyssou E; Tubiana R; Soulie C; Valantin MA; Katlama C; Calvez V; Assoumou L; Marcelin AG; Pourcher V
    J Infect; 2022 Aug; 85(2):e33-e36. PubMed ID: 35662666
    [No Abstract]   [Full Text] [Related]  

  • 6. Potential drawbacks of SARS-CoV-2 seroprevalence surveys.
    Lippi G
    J Hosp Infect; 2021 Apr; 110():206. PubMed ID: 33358929
    [No Abstract]   [Full Text] [Related]  

  • 7. Seroprevalence of antibodies against SARS-CoV-2 in a large national hospital and affiliated facility in Tokyo, Japan.
    Tanaka A; Yamamoto S; Miyo K; Mizoue T; Maeda K; Sugiura W; Mitsuya H; Sugiyama H; Ohmagari N
    J Infect; 2021 Apr; 82(4):e1-e3. PubMed ID: 33524423
    [No Abstract]   [Full Text] [Related]  

  • 8. Population SARS-CoV-2 Seroprevalence Using Antenatal Serum Samples in British Columbia, Canada.
    McClymont E; Elwood C; Sekirov I; Morshed M; Levett P; Liu A; Jassem A; Sbihi H; Ogilvie G; Krajden M; Money D
    J Obstet Gynaecol Can; 2021 Nov; 43(11):1242-1243. PubMed ID: 34758903
    [No Abstract]   [Full Text] [Related]  

  • 9. Seroprevalence of SARS-Cov-2 in 646 professionals at the Rothschild Foundation Hospital (ProSeCoV study).
    Mesnil M; Joubel K; Yavchitz A; Miklaszewski N; Devys JM
    Anaesth Crit Care Pain Med; 2020 Oct; 39(5):595-596. PubMed ID: 32861816
    [No Abstract]   [Full Text] [Related]  

  • 10. Seroprevalence of SARS-CoV-2 IgG specific antibodies among healthcare workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave.
    Barallat J; Fernández-Rivas G; Quirant-Sánchez B; González V; Doladé M; Martinez-Caceres E; Piña M; Matllo J; Estrada O; Blanco I
    PLoS One; 2020; 15(12):e0244348. PubMed ID: 33370363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing for COVID-19: a few points to remember.
    Krátká Z; Luxová Š; Malíčková K; Fürst T; Šimková H
    Cas Lek Cesk; 2020; 159(2):72-77. PubMed ID: 32434339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 antibody seroprevalence in patients receiving dialysis in the USA.
    Flower B; Atchison C
    Lancet; 2020 Oct; 396(10259):1308-1309. PubMed ID: 32987009
    [No Abstract]   [Full Text] [Related]  

  • 13. SARS-CoV-2-Specific Antibody Detection for Seroepidemiology: A Multiplex Analysis Approach Accounting for Accurate Seroprevalence.
    den Hartog G; Schepp RM; Kuijer M; GeurtsvanKessel C; van Beek J; Rots N; Koopmans MPG; van der Klis FRM; van Binnendijk RS
    J Infect Dis; 2020 Oct; 222(9):1452-1461. PubMed ID: 32766833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of SARS-CoV-2 antibodies among firefighters/paramedics of a US fire department: a cross-sectional study.
    Caban-Martinez AJ; Schaefer-Solle N; Santiago K; Louzado-Feliciano P; Brotons A; Gonzalez M; Issenberg SB; Kobetz E
    Occup Environ Med; 2020 Dec; 77(12):857-861. PubMed ID: 32764107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan.
    Yamamoto S; Tanaka A; Oshiro Y; Ishii M; Ishiwari H; Konishi M; Matsuda K; Ozeki M; Miyo K; Maeda K; Mizoue T; Sugiura W; Mitsuya H; Sugiyama H; Ohmagari N
    J Infect; 2021 Aug; 83(2):237-279. PubMed ID: 34044036
    [No Abstract]   [Full Text] [Related]  

  • 16. Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare workers with differing levels of coronavirus disease 2019 (COVID-19) patient exposure.
    Hunter BR; Dbeibo L; Weaver CS; Beeler C; Saysana M; Zimmerman MK; Weaver L
    Infect Control Hosp Epidemiol; 2020 Dec; 41(12):1441-1442. PubMed ID: 32741406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-SARS-CoV-2 vaccination specific antibody decrease - Thresholds for determining seroprevalence and seroneutralization differ.
    Douxfils J; Gillot C; Mullier F; Favresse J
    J Infect; 2021 Oct; 83(4):e4-e5. PubMed ID: 34407421
    [No Abstract]   [Full Text] [Related]  

  • 18. Seroprevalence of SARS-CoV-2-Specific Antibodies, Faroe Islands.
    Petersen MS; Strøm M; Christiansen DH; Fjallsbak JP; Eliasen EH; Johansen M; Veyhe AS; Kristiansen MF; Gaini S; Møller LF; Steig B; Weihe P
    Emerg Infect Dis; 2020 Nov; 26(11):2761-2763. PubMed ID: 32726200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are Seroprevalence Estimates for Severe Acute Respiratory Syndrome Coronavirus 2 Biased?
    Takahashi S; Greenhouse B; Rodríguez-Barraquer I
    J Infect Dis; 2020 Nov; 222(11):1772-1775. PubMed ID: 32856712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 seroprevalence in a Belgian cohort of patients with cystic fibrosis.
    Berardis S; Verroken A; Vetillart A; Struyf C; Gilbert M; Gruson D; Gohy S
    J Cyst Fibros; 2020 Nov; 19(6):872-874. PubMed ID: 32828701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.